May 16, 2022 | Oxford Technology Park
Life Science REIT (AIM: LABS), the real estate investment trust focused on UK life science properties has completed the acquisition of Oxford Technology Park (“OTP”), a 20 acre science and technology park which, once fully developed, will comprise up to 450,000 sq ft...
Mar 28, 2022 | Member News, Oxford Technology Park
The construction of an impressive high-tech purpose-built R&D and manufacturing facility, which will be a vital hub for one of the world’s leading suppliers of reagents enabling research into diagnostics and vaccines for emerging and endemic infectious diseases,...
Nov 4, 2020 | Member News, Oxford Technology Park
The Native Antigen Company, one of the world’s leading suppliers of infectious disease antigens and antibodies, has signed a pre-let for a new purpose-built R&D and manufacturing facility at the Oxford Technology Park. It follows the acquisition of The Native...
